Cerus Debt to Equity Ratio 2010-2024 | CERS

Current and historical debt to equity ratio values for Cerus (CERS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cerus debt/equity for the three months ending June 30, 2024 was 1.19.
Cerus Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-06-30 $0.14B $0.05B 2.69
2024-03-31 $0.14B $0.05B 2.77
2023-12-31 $0.14B $0.05B 2.70
2023-09-30 $0.16B $0.05B 3.20
2023-06-30 $0.15B $0.05B 2.85
2023-03-31 $0.15B $0.06B 2.52
2022-12-31 $0.15B $0.07B 2.18
2022-09-30 $0.14B $0.07B 1.91
2022-06-30 $0.14B $0.08B 1.82
2022-03-31 $0.14B $0.08B 1.76
2021-12-31 $0.15B $0.09B 1.77
2021-09-30 $0.14B $0.08B 1.70
2021-06-30 $0.14B $0.08B 1.65
2021-03-31 $0.13B $0.09B 1.38
2020-12-31 $0.12B $0.10B 1.13
2020-09-30 $0.10B $0.11B 0.95
2020-06-30 $0.10B $0.12B 0.88
2020-03-31 $0.10B $0.11B 0.92
2019-12-31 $0.11B $0.06B 1.90
2019-09-30 $0.10B $0.06B 1.70
2019-06-30 $0.11B $0.07B 1.66
2019-03-31 $0.11B $0.07B 1.53
2018-12-31 $0.08B $0.09B 0.93
2018-09-30 $0.07B $0.09B 0.76
2018-06-30 $0.06B $0.09B 0.68
2018-03-31 $0.06B $0.09B 0.69
2017-12-31 $0.06B $0.04B 1.52
2017-09-30 $0.06B $0.04B 1.61
2017-06-30 $0.04B $0.04B 1.13
2017-03-31 $0.04B $0.04B 1.05
2016-12-31 $0.05B $0.06B 0.79
2016-09-30 $0.04B $0.07B 0.61
2016-06-30 $0.05B $0.08B 0.61
2016-03-31 $0.04B $0.08B 0.53
2015-12-31 $0.05B $0.10B 0.47
2015-09-30 $0.04B $0.10B 0.42
2015-06-30 $0.04B $0.11B 0.37
2015-03-31 $0.03B $0.11B 0.30
2014-12-31 $0.04B $0.04B 0.97
2014-09-30 $0.03B $0.05B 0.68
2014-06-30 $0.03B $0.04B 0.74
2014-03-31 $0.03B $0.05B 0.63
2013-12-31 $0.04B $0.04B 0.95
2013-09-30 $0.04B $0.04B 1.23
2013-06-30 $0.03B $0.06B 0.50
2013-03-31 $0.03B $0.06B 0.52
2012-12-31 $0.03B $0.02B 1.56
2012-09-30 $0.03B $0.02B 1.88
2012-06-30 $0.03B $0.02B 1.49
2012-03-31 $0.03B $0.02B 1.69
2011-12-31 $0.03B $0.02B 1.48
2011-09-30 $0.02B $0.02B 1.26
2011-06-30 $0.03B $0.01B 1.95
2011-03-31 $0.03B $0.02B 1.39
2010-12-31 $0.02B $0.02B 1.03
2010-09-30 $0.02B $0.01B 1.61
2010-06-30 $0.02B $0.01B 1.48
2010-03-31 $0.02B $0.02B 0.91
2009-12-31 $0.01B $0.02B 0.61
2009-09-30 $0.02B $0.03B 0.67
2009-06-30 $0.01B $0.02B 0.60
2009-03-31 $0.01B $0.03B 0.43
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.351B $0.156B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $201.960B 25.76
Stryker (SYK) United States $147.572B 33.26
Boston Scientific (BSX) United States $130.758B 37.59
Medtronic (MDT) Ireland $113.242B 16.85
EssilorLuxottica (ESLOY) France $110.003B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.726B 0.00
Haleon (HLN) United Kingdom $42.008B 27.29
GE HealthCare Technologies (GEHC) United States $38.798B 20.12
ResMed (RMD) United States $36.289B 29.82
Terumo (TRUMY) Japan $29.859B 42.17
Koninklijke Philips (PHG) Netherlands $24.401B 18.68
Zimmer Biomet Holdings (ZBH) United States $21.886B 13.93
Insulet (PODD) United States $19.297B 76.84
Baxter (BAX) United States $17.259B 11.24
Smith & Nephew SNATS (SNN) United Kingdom $10.746B 0.00
Bio-Rad Laboratories (BIO) United States $10.206B 34.68
BellRing Brands (BRBR) United States $9.277B 39.22
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $5.920B 13.76
TG Therapeutics (TGTX) United States $4.812B 0.00
Haemonetics (HAE) United States $4.690B 22.89
ICU Medical (ICUI) United States $4.348B 41.49
Prestige Consumer Healthcare (PBH) United States $4.033B 20.06
Perrigo (PRGO) Ireland $3.598B 10.59
Envista Holdings (NVST) United States $3.531B 26.31
Agios Pharmaceuticals (AGIO) United States $3.366B 0.00
Neogen (NEOG) United States $3.324B 38.35
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.961B 18.99
QuidelOrtho (QDEL) United States $2.767B 17.81
LeMaitre Vascular (LMAT) United States $2.322B 56.43
Warby Parker (WRBY) United States $2.158B 0.00
Green Thumb Industries (GTBIF) United States $1.894B 33.15
AtriCure (ATRC) United States $1.786B 0.00
InMode (INMD) Israel $1.618B 9.73
Maravai LifeSciences Holdings (MRVI) United States $1.438B 0.00
AdaptHealth (AHCO) United States $1.437B 10.28
Curaleaf Holdings (CURLF) Canada $1.326B 0.00
BioLife Solutions (BLFS) United States $1.223B 0.00
Phibro Animal Health (PAHC) United States $1.015B 17.90
Owens & Minor (OMI) United States $0.997B 7.79
CeriBell (CBLL) United States $0.981B 0.00
National Vision Holdings (EYE) United States $0.889B 29.71
Capricor Therapeutics (CAPR) United States $0.822B 0.00
Evolus (EOLS) United States $0.788B 0.00
Verano Holdings (VRNOF) United States $0.678B 0.00
Cresco Labs (CRLBF) United States $0.615B 0.00
VAREX IMAGING (VREX) United States $0.585B 17.67
Quanterix (QTRX) United States $0.582B 0.00
Surmodics (SRDX) United States $0.550B 0.00
Valneva SE (VALN) France $0.389B 0.00
ZimVie (ZIMV) United States $0.389B 32.74
Canopy Growth (CGC) Canada $0.370B 0.00
Viemed Healthcare (VMD) United States $0.366B 34.81
OraSure Technologies (OSUR) United States $0.309B 20.70
Sanara MedTech (SMTI) United States $0.303B 0.00
Biote (BTMD) United States $0.299B 6.57
Zynex (ZYXI) United States $0.273B 57.13
Aurora Cannabis (ACB) Canada $0.259B 0.00
MacroGenics (MGNX) United States $0.257B 0.00
Omeros (OMER) United States $0.247B 0.00
Utah Medical Products (UTMD) United States $0.238B 16.01
Jin Medical (ZJYL) China $0.223B 0.00
TerrAscend (TSNDF) Canada $0.220B 0.00
High Tide (HITI) Canada $0.216B 89.67
Organigram Holdings (OGI) Canada $0.173B 0.00
Brainsway (BWAY) Israel $0.162B 97.00
FitLife Brands (FTLF) United States $0.155B 20.96
Zevia PBC (ZVIA) United States $0.152B 0.00
TriSalus Life Sciences (TLSI) United States $0.136B 0.00
Quipt Home Medical (QIPT) United States $0.116B 0.00
Ayr Wellness (AYRWF) United States $0.098B 0.00
Fonar (FONR) United States $0.098B 11.03
Veru (VERU) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.40
Rockwell Medical (RMTI) United States $0.088B 47.17
Cellectar Biosciences (CLRB) United States $0.087B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.69
Modular Medical (MODD) United States $0.074B 0.00
Jushi Holdings (JUSHF) United States $0.069B 0.00
MariMed (MRMD) United States $0.063B 0.00
InterCure (INCR) Israel $0.061B 0.00
Safety Shot (SHOT) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
Exagen (XGN) United States $0.049B 0.00
Allurion Technologies (ALUR) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.029B 0.00
Nephros (NEPH) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
GlucoTrack (GCTK) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.60
SNDL (SNDL) Canada $0.000B 0.00